Summary
Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises, Inc. is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company offers products for the treatment of osteoarthritis of the knee and for the treatment of diabetic macular edema. Its products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Ampio’s ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company is conducting research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.
Ampio Pharmaceuticals Inc (AMPE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ampio Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10
Venture Financing 11
Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11
Merger 11
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11
Equity Offering 12
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14
Ampio Pharmaceuticals Inc - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
Mar 20, 2017: Ampio Pharmaceuticals Provides Corporate Update 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List of Tables
Ampio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2015 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ampio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ampio Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Ampio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ampio Pharma Completes Acquisition Of Rights Of Drug Delivery Technology From Valeant International 10
Luoxis Diagnostics To Raise US$5 Million In Venture Financing 11
Rosewind Merges with Vyrix Pharma and Luoxis Diagnostics in Reverse Merger Transaction 11
Ampio Pharma Completes Public Offering Of Shares For US$68.4 Million 12
Ampio Pharma Completes Private Placement Of Shares For US$25.3 Million 13
Ampio Pharma Completes First Tranche Of Private Placement Of Shares 14
Ampio Pharmaceuticals Inc, Key Competitors 16
Ampio Pharmaceuticals Inc, Key Employees 17
Ampio Pharmaceuticals Inc, Subsidiaries 18
List of Figures
Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Ampio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Ampio Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8